Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Apr 29, 2012
Ringold thinks that biotech companies are fighting the consequences of what to place in the bubble of dotcoms. The bubble was not based on reality. Now it is hard for good companies to get funding, he says.